Amcenestrant
SAR439859 (compound 43d) is an orally active, non-steroidal, and selective estrogen receptor degrader (SERD) . SAR439859 is an effective ER antagonist with ER degradation activity, an EC50 of 0.2 nM. SAR439859 can show potent anti-tumor effects and limited cross-resistance in ER+ breast cancer.
Product Specifications
CAS Number
2114339-57-8
Product Name Alternative
SAR439859
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sar439859.html
Purity
99.79
Solubility
DMSO : 83.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC=C(C(C2=CC=C(O[C@@H]3CN(CCCF)CC3)C=C2)=C(C4=CC=C(Cl)C=C4Cl)CCC5)C5=C1)O
Molecular Formula
C31H30Cl2FNO3
Molecular Weight
554.48
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
+
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
ERα
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-GNAQ Antibody Picoband® Fluoro594 Conjugated
BCO2 (BCDO2, B-DIOX-II, beta-carotene 9',10'-oxygenase) discontinued